Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 25Sanofi
01 7Injectable Solution
02 1Lixisenatide 10Mcg 3Ml 1 Units Parenteral Use
03 1Lixisenatide 10Mcg+20Mcg 3Ml 1+1 Units Parenteral Use
04 1Lixisenatide 20Mcg 3Ml 2 Units Parenteral Use
05 4PED
06 1SOLUTION
07 3SOLUTION;SUBCUTANEOUS
08 7Solution For Injection
01 2Allowed
02 2Approved
03 5Authorized
04 4Originator
05 6Prescription
06 6Blank
01 2ADLYXIN
02 9Lyxumia
03 1SOLIQUA
04 1SOLIQUA 100/33
05 2SOLIQUA 33/100
06 2SOLIQUA 50/100
07 8Suliqua
01 1Canada
02 5Denmark
03 3Italy
04 4South Africa
05 5Spain
06 2Sweden
07 2Switzerland
08 3USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : ADLYXIN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.15MG/3ML (0.05MG/ML)
Packaging :
Approval Date :
Application Number : 208471
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : ADLYXIN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.3MG/3ML (0.1MG/ML)
Packaging :
Approval Date :
Application Number : 208471
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
INSULIN GLARGINE; LIXISENATIDE
Brand Name : SOLIQUA 100/33
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML)
Packaging :
Approval Date :
Application Number : 208673
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 10Mcg 3Ml 1 Units Parenteral Use
Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 20Mcg 3Ml 2 Units Parenteral Use
Dosage Strength : 2 cartridges SC in preriemp pen 3 ml 20 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 10Mcg+20Mcg 3Ml 1+1 Units Parenteral Use
Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg + 1 cartridge SC in preriemp pen 3 ml 20 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100mg;50mg
Packaging :
Approval Date : 05/10/2017
Application Number : 66283
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100mg;33mg
Packaging :
Approval Date : 05/10/2017
Application Number : 66283
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Solution For Injection
Dosage Strength : 100IU/ml;33mcg/ml
Packaging :
Approval Date : 11/01/2017
Application Number : 20160309000010
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Solution For Injection
Dosage Strength : 100IU/ml;50mcg/ml
Packaging :
Approval Date : 11/01/2017
Application Number : 20160309000027
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100UNIT; 33 MCG
Packaging :
Approval Date : 03-02-2017
Application Number : 1161157004
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100UNIT; 50MCG
Packaging :
Approval Date : 03-02-2017
Application Number : 1161157002
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Lyxumia
Dosage Form : Injectable Solution
Dosage Strength : 10MCG
Packaging :
Approval Date : 13-02-2013
Application Number : 12811001
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Lyxumia
Dosage Form : Injectable Solution
Dosage Strength : 20MCG
Packaging :
Approval Date : 13-02-2013
Application Number : 12811003
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Lyxumia
Dosage Form : Injectable Solution
Dosage Strength : 10MCG;20MCG
Packaging :
Approval Date : 13-02-2013
Application Number : 12811005
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SOLIQUA
Dosage Form : SOLUTION
Dosage Strength : 33MCG/ML
Packaging :
Approval Date :
Application Number : 2478293
Regulatory Info : Prescription
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : SOLIQUA 33/100
Dosage Form : PED
Dosage Strength : 33mg/ml
Packaging : 1X1IU/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : SOLIQUA 33/100
Dosage Form : PED
Dosage Strength : 33mg/ml
Packaging : 1X3IU/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : SOLIQUA 50/100
Dosage Form : PED
Dosage Strength : 50mg/ml
Packaging : 1X1IU/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : SOLIQUA 50/100
Dosage Form : PED
Dosage Strength : 50mg/ml
Packaging : 1X3IU/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
